Swiss National Bank’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
39,357
-5,400
-12% -$163K ﹤0.01% 2107
2026
Q1
$1.26M Hold
44,757
– – ﹤0.01% 2064
2025
Q4
$1.24M Buy
44,757
+2,400
+6% +$57.8K ﹤0.01% 2079
2025
Q3
$1.06M Buy
42,357
+16,100
+61% +$357K ﹤0.01% 2147
2025
Q2
$462K Hold
26,257
– – ﹤0.01% 2315
2025
Q1
$412K Hold
26,257
– – ﹤0.01% 2366
2024
Q4
$503K Hold
26,257
– – ﹤0.01% 2406
2024
Q3
$486K Buy
+26,257
New +$480K ﹤0.01% 2436

Other funds holding PHVS

Swiss National Bank's PHVS Position: Q2 2026 in Review

Swiss National Bank reduced its Pharvaris (PHVS) stake by 12% in Q2 2026, selling an estimated $163K and leaving 39,357 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2107.

Swiss National Bank first reported a position in PHVS in Q3 2024 and has held it in 8 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Swiss National Bank held 39,357 shares of Pharvaris worth $1.36M as of Q2 2026.
  • Swiss National Bank sold 5,400 Pharvaris shares in Q2 2026, an estimated $163K.
  • Pharvaris made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2107 holding.
  • Swiss National Bank first reported a position in Pharvaris in Q3 2024 and has held it in 8 quarters since.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.